pharmaphorum

MAY 17, 2021

Many life sciences companies have begun 2021 by reviewing how they respond to the longer-term impact of this change – and its impact on sales forces is a major topic. Sales force adoption (48% of respondents) was deemed a key success factor for omnichannel engagement with HCPs in the ‘next normal’ (IQVIA survey, March 2021).

Life Science 72

Life Science Sales Marketing Development 72

Pharmaceutical Technology

JULY 6, 2022

Business optimism improved in June 2022 compared to May 2022, even amid concerns over rising costs and slowing demand, revealed an analysis of an ongoing poll by Verdict. Analysis of the poll responses recorded in June 2022 shows that optimism regarding future growth prospects increased by five percentage points to 63% from 58% in May 2022.

Manufacturing 130

Manufacturing Production Sales Marketing 130

Pharmaceutical Technology

SEPTEMBER 6, 2022

Verdict has been conducting the poll to study the trends in business optimism during COVID-19 as reflected by the views of companies on their future growth prospects amid the pandemic. The analysis is based on 321 responses received from the readers of Verdict network sites between 01 August and 31 August 2022.

Sales 130

Sales Marketing Manufacturing 130

pharmaphorum

NOVEMBER 2, 2020

Digital therapeutics are gaining momentum worldwide and offer developers, including pharma, both a huge opportunity and a stimulating market access challenge, say Olaf Schoeman and Emanuele Arcà. Thriving in COVID-19 with flexible marketing strategies. Pharma sales is set to change forever.

Sales 58

Sales Clinical Trials Clinical Trials Marketing 58

pharmaphorum

DECEMBER 7, 2022

Pricing and market access in France operate on a dual system, under which health technology assessments (HTAs) are conducted separately from pricing negotiations. Source: CT assessments [Haute Autorité de Santé website]; ANSM [Agence Nationale de Sécurité du Médicament et des Produits de Santé]; CRA analysis). Source: CRA analysis).

Drugs 104

Drugs Life Science Production Manufacturing 104

pharmaphorum

SEPTEMBER 17, 2020

In this issue we hear from a variety of KOLs who are leading pharma comms into a new, digital era to get their views on how pharma can best adapt for the post-COVID world. OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharma.

Marketing 52

Marketing Sales Research Development 52

pharmaphorum

APRIL 1, 2022

However, while this dramatic shake-up of the UK Market Access environment aims to improve care for patients and providers for life science companies, this unfamiliar territory presents both opportunities and challenges. The post ICSs – an opportunity to improve Patient & Market Access at a local level appeared first on.

Marketing 98

Marketing Life Science Pharmacy Sales 98

Pharma Marketing Network

JULY 21, 2021

The summit consisted of three panel discussions: “Coordinated CX: Moving Beyond Campaign Management,” “Digital Customer Experience and Analytics,” and “The Engagement Matrix: A Holistic View of CX.” Lars Merk , Senior Global Marketing Director at AstraZeneca , spoke to the connection between customer centricity and the evolution of CX. “We

Sales 52

Sales Marketing Branding Production 52

pharmaphorum

JUNE 20, 2022

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan drug market and forecasts what the future of the industry holds based on data. Revising legislation.

Drugs 52

Drugs Marketing Life Science Regulation 52

The Pharma Data

DECEMBER 8, 2020

Copies of the final prospectus supplement and the accompanying prospectus relating to the offering, when available, may be obtained from: Citigroup, by mail at Citigroup Global Markets Inc., View source version on businesswire.com: [link]. Source link.

Sales 52

Sales Marketing Containment Development 52

Pharma Marketing Network

JULY 21, 2021

The summit consisted of three panel discussions: “Coordinated CX: Moving Beyond Campaign Management,” “Digital Customer Experience and Analytics,” and “The Engagement Matrix: A Holistic View of CX.” Lars Merk , Senior Global Marketing Director at AstraZeneca , spoke to the connection between customer centricity and the evolution of CX. “We

Sales 52

Sales Marketing Branding Production 52

Pharmaceutical Technology

OCTOBER 7, 2022

Verdict has been conducting the poll to study the trends in business optimism during COVID-19 as reflected by the views of companies on their future growth prospects amid the pandemic. The analysis is based on 373 responses received from the readers of Verdict network sites between 01 September and 30 September 2022. from 103.0

Manufacturing 130

Manufacturing Sales Production Marketing 130

pharmaphorum

DECEMBER 14, 2020

As this issue’s title suggests, patient centricity is about more than just talking points and marketing strategies – it requires companies to truly listen to, engage with and partner with the patients they serve, and in putting this month’s Deep Dive together it’s been great to see that so many pharma firms are now taking this to heart.

Clinical Trials 75

Clinical Trials Clinical Trials Trials Marketing 75

pharmaphorum

APRIL 16, 2021

The launch environment was directly impacted by the COVID-19 pandemic, which hit two key drivers of launch uptake particularly hard: the dynamic market, i.e. new and switch prescriptions, and face-to-face interactive engagement with healthcare professionals. Here we assess the launches of New Active Substances (NAS) only.

Sales 95

Sales Marketing Medicine Doctors 95

pharmaphorum

FEBRUARY 26, 2021

Emma Sutcliffe from NexGen Healthcare Communications looks at how patient insights can bring the invisible challenges of living with a rare condition into plain view. Focus on Rare: the invisible burden of rare diseases. Digitalising drug discovery.

Development 58

Development Research Pharma Companies Vaccination 58

pharmaphorum

JANUARY 22, 2021

In this article, we focus in particular on how COVID-19 may be changing prescribing decisions using market research and claims data. Analysis of prescribing changes. Source: CRA market research (conducted June 2020). Source: CRA claims data analysis (using claims through June 2020). Changes in Prescribing by Specialty.

Pharmacy 104

Pharmacy Marketing Research Nurses 104

Delveinsight

SEPTEMBER 8, 2021

The activities can include procedures like competitive analysis, corporate strategy, operations management, and human resources. Grabbing market opportunities, identifying relevant supplies and equipment, product design & development, planning out capitalization, focusing on promotions, etc.

Production 52

Production Marketing Pharma Companies Development 52

pharmaphorum

JANUARY 24, 2023

As the analysis in our graphic shows, the only exception where engagement volumes have recovered is the US. A longer historic view of biotech funding, however, reverses the picture: 2020 and 2021 were not normal years. Venture capital poured into the pandemic biotech markets and not every investment was good quality.

Medicine 98

Medicine Manufacturing Regulation Marketing 98

pharmaphorum

FEBRUARY 11, 2022

“It’s our representation of tracking the deidentified, which is important from a privacy and compliance point of view,” Sun says. “It For example, Komodo has modules in their solutions suite allowing users to view the diagnostic journey of a patient who’s had a confirmatory diagnosis. “We ” About the interviewee.

Life Science 104

Life Science Engineer Development Big Data 104

pharmaphorum

MAY 14, 2021

Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage. This article appears in our digital magazine, Deep Dive: Market Access 2021. It’s important to remember that the UK market represents only 2.5% This additional effort could lead to poorer patient access. “It

Marketing 58

Marketing Regulation Medicine Life Science 58

The Pharma Data

JANUARY 19, 2021

The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA® and other Super Fruit Nutraceutical products. There is also no assurance the Company will generate significant revenue in global nutraceutical and dietary supplements markets. Source link.

Production 40

Production Marketing Licensing Licensing 40

The Pharma Data

DECEMBER 1, 2020

Under the contract, RSA Biomedical will now offer Sectra CT-based Micromotion Analysis (Sectra CTMA®). “For the past two decades, we have supported orthopaedists and implant manufacturers by providing measurement methods for validating implants and our brand is market leading in terms of quality. SOURCE Sectra.

Sales 40

Sales Manufacturing Containment Branding 40

The Pharma Data

MAY 15, 2023

Before joining EMMI Group as CEO, he was a Member of the Executive Board and Head of the Marketing Department at Migros-Genossenschafts-Bund. He holds a Master degree in Marketing and Trade from the University of St. Urs Riedener, was CEO of Swiss consumer goods company EMMI Group between 2008 and 2022. Gallen (HSG), Switzerland.

Sales 40

Sales Production Doctors Doctor 40

The Pharma Data

OCTOBER 18, 2020

BOSTON–( BUSINESS WIRE )– AVEO Oncology (Nasdaq: AVEO) today announced the appointment of David Crist as Vice President of Sales. Mr. Crist brings more than twenty years of oncology sales experience in both launch-stage and late-stage companies, building commercial organizations and developing high performing sales force teams.

Sales 52

Sales Clinical Trials Clinical Trials Containment 52

The Pharma Data

DECEMBER 16, 2020

Aurinia will receive tiered royalties ranging from 10 to 20 percent (dependent on achievement of sale milestones) on net sales upon commercialization, along with additional milestone payments based on the attainment of certain annual sales by Otsuka. and has the potential to receive up to $50 million U.S. based in Japan.

Licensing 52

Licensing Licensing Development Sales 52

XTalks

DECEMBER 15, 2020

The plant-based market is growing in the mainstream food market and will expand into various categories in 2021. Technology breakthroughs have provided consumers with a variety of personalized nutrition options,” says Chang Liu, market analyst at Innova Market Insights. But in my view, meal kits are just a hybrid.

Production 98

Production Manufacturing Marketing Sales 98

The Pharma Data

DECEMBER 28, 2020

Combining next generation sequencing (“NGS”) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs.

Genetics 52

Genetics Sales Gene Sequencing Marketing 52

The Pharma Data

DECEMBER 16, 2020

The partnership leverages Evotec’s proprietary PanOmics platform, which combines enhanced throughput proteomics, high throughput transcriptomics and cell imaging with an integrated data analysis platform PanHunter. Media Contact Evotec SE: Gabriele Hansen, SVP Head of Global Corporate Communications & Marketing, Phone: +49.(0)40.56081-255,

Protein 40

Protein Containment Bioinformatics Drugs 40

Pharma in Brief

JULY 7, 2020

Galderma ), markets two adapalene products in Canada: Differin ® , which contains 0.1% Board Staff appealed the Federal Court’s decision and, as we reported , the Federal Court of Appeal ( FCA ) found that the PMPRB’s patent-pertaining analysis was unreasonable. Clinical similarities used to ground patent-pertaining analysis.

Medicine 40

Medicine Dermatology Containment Production 40

The Pharma Data

OCTOBER 28, 2020

LONDON–( BUSINESS WIRE )– LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2020. For the third quarter of 2020, worldwide sales from continuing operations were $240.1 Total Net Sales.

Sales 40

Sales Production Compliance Marketing 40

The Pharma Data

NOVEMBER 4, 2020

Net sales of $895 million declined 7.0%. Organic sales declined 8.8%. Don Casey, CEO commented: “Our third quarter results reflect a recovery in global dental markets, the actions we took to address pandemic related challenges, and the ongoing structural changes designed to improve our performance over the long-term.

Sales 40

Sales Production Manufacturing Marketing 40

XTalks

DECEMBER 15, 2020

The plant-based market is growing in the mainstream food market and will expand into various categories in 2021. Technology breakthroughs have provided consumers with a variety of personalized nutrition options,” says Chang Liu, market analyst at Innova Market Insights. But in my view, meal kits are just a hybrid.

Production 52

Production Manufacturing Marketing Sales 52

The Pharma Data

DECEMBER 10, 2020

The ADSs have been approved for listing on the Nasdaq Global Select Market and are expected to begin trading on December 11, 2020 under the ticker symbol “NBTX.” The Company’s ordinary shares are listed on the regulated market of Euronext Paris under the ticker symbol “NANO.”.

Marketing 52

Marketing Regulation Sales Containment 52

pharmaphorum

DECEMBER 29, 2022

The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis. COVID-19 erupted, mutated, and was supplemented by the challenges of monkeypox and the need to catch up with major treatment and immunisation backlogs accumulated during the pandemic.

Manufacturing 110

Manufacturing Medicine Pharma Companies Engineer 110

The Pharma Data

NOVEMBER 5, 2020

resolving patent litigation brought in response to Teva’s Abbreviated New Drug Application, seeking approval to market a generic version of Xtampza ER prior to the expiration of Collegium’s applicable patents. Reached a settlement with Teva Pharmaceutical USA, Inc. FDA approval, and customary exceptions).

Production 52

Production Marketing Sales Manufacturing 52

pharmaphorum

DECEMBER 28, 2022

In turn, the acquiring company will help the novel drugs navigate the complexities and costs of regulations and benefit from market access and economies of scale. Conducting internal pre-sale checks and looking at your level of compliance and licenses is a vital exercise. Looking beyond balance sheets. About the author.

Compliance 118

Compliance Regulation Manufacturing Licensing 118

pharmaphorum

DECEMBER 12, 2022

The demand for high-calibre, sharply-focussed clinical knowledge and data is increasing as HCPs streamline and recalibrate their engagements with the pharmaceutical sector.

DNA 104

DNA Branding Sales Marketing 104